跳至主要内容
临床试验/NCT03343288
NCT03343288已完成不适用

The Use of Silver Doped Calcium Phosphate Based Ceramic Coated Orthopedic Implants for Preventing Implant Related Infection

Eskisehir Osmangazi University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Number of pin site with positive culture resuls

研究概览

简要总结

In this study, CE (European Conformity) marked, domestic manufactured standard orthopedic implants will be used after silver HA coating with electrospray method in 30 patients requiring hip joint prostheses, intramedullary nails or external fixator in 30 patients to antimicrobial effectiveness. These patients will be tasted for liver and kidney functions and blood and urine silver levels in addition to routine tests such as full blood, complete biochemistry, C-reactive protein, erythrocyte sedimentation rate required in the normal diagnosis and treatment processes,

详细描述

In this study, considering the differences in bone contact surface area and interactions; hip joint prostheses, intramedullary nails and external fixator implants to be used in 30 patients . CE (European Conformity) marked, domestic manufactured standard orthopedic implants will be used in patients after silver HA coating with electrospray method. These patients will be tasted for the evaluation of liver and kidney functions and blood and urine silver levels in addition to routine tests such as full blood, complete biochemistry, C-reactive protein, erythrocyte sedimentation rate required in the normal diagnosis and treatment processes, and will be monitored for at least 12 months. The performance of coating to be applied and any unwanted side effects in normal conditions of use will be evaluated..

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women between the ages of 18-65
  • Patients without heart, lung, renal or hepatic insufficiency
  • Patients without epilepsy, cerebrovascular attack or ischaemia
  • Patients without antibiotic allergy
  • Patients who have low immune defense mechanisms such as malignancy, diabetes mellitus, polytrauma, and open fracture
  • Patients using oral or parenteral corticosteroids, methotrexate, cyclosporine or other immunosuppressive drugs - -

排除标准

  • Pregnant women
  • Patients with another silver implant in their body, such as a silver-coated stent
  • Patients with known allergy or hypersensitivity to silver
  • Patients with too many antibiotics due to recurrent infections

结局指标

主要结局

Number of pin site with positive culture resuls

时间窗: 12 months

incidence of pin tract infection

次要结局

  • Number of patient with elevated BUN levels(12 months)
  • Number of patient with elevated blood silver(12 months)
  • Number of patient with elevated level of serum ALT levels(12 months)

研究者

发起方
Eskisehir Osmangazi University
申办方类型
Other
责任方
Principal Investigator
主要研究者

NUSRET KOSE

Professor of Orhopedics and Traumatology

Eskisehir Osmangazi University

研究点 (2)

Loading locations...

相似试验